SinghS, TyagiAK, RamanS, et al.Genome-based multitargeting of cancer: Hype or hope? In: GandhiV, MehtaK, GroverR, et al., eds. Multi-Targeted Approach to Treatment of Cancer. Heidelberg: Springer, 2015.
2.
WoolfEC, ScheckAC. Metabolism and glioma therapy. CNS Oncol, 2012; 1:7–10.
3.
SafdieFM. Fasting and cancer treatment in humans: A case series report. Aging, 2009; 1:988–1007.
4.
FineEJ, Segal-IsaacsonCJ, FeinmanRD, et al.Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients. Nutrition, 2012; 28:1028–1035.
5.
KlementRJ, ChampCE. Calories, carbohydrates, and cancer therapy with radiation: Exploiting the five R's through dietary manipulation. Cancer Metastasis Rev, 2014; 33:217–229.
6.
DowlingRJO, GoodwinPJ, StambolicV. Understanding the benefit of metformin use in cancer treatment. BMC Med, 2011; 9:33.
7.
National Cancer Institute. Metformin: Can a Diabetes Drug Help Prevent Cancer?. 2013. Online document at: www.cancer.gov/cancertopics/research-updates/2013/metformin Accessed May22, 2015.
8.
National Diabetes Information Clearinghouse (NDIC). Diabetes Prevention Program (DPP). Online document at: http://diabetes.niddk.nih.gov/dm/pubs/preventionprogram/ Accessed May22, 2015.
9.
KamińskiS. Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet, 2007; 48:189–198.
10.
ZhangC, CaoS, TooleBP, XuY. Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: A model for solid-cancer initiation and early development. Int J Cancer, 2015; 136:2001–2011.
11.
GyöngyiZ, BudánF, SzabóI, et al.Deuterium depleted water effects on survival of lung cancer patients and expression of Kras, Bcl2, and Myc genes in mouse lung. Nutr Cancer, 2013; 65:240–246.
12.
NuvoliB, SantoroR, CatalaniS, et al.CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways. J Exp Clin Cancer Res, 2014; 33:24.
13.
CatalaniS, CarbonaroV, PalmaF, et al.Metabolism modifications and apoptosis induction after Cellfoodtm administration to leukemia cell lines. J Exp Clin Cancer Res, 2013; 32:63.
14.
TomaselliF, MaierA, SankinO, et al.Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer. Lasers Surg Med, 2001; 28:399–403.
15.
MaierA, TomaselliaF, AneggaU, et al.Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg, 2000; 18:649–654.
16.
ChenQ, HuangZ, ChenH, et al.Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapy. Photochem Photobiol, 2002; 76:197–203.
17.
World Health Organization. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. Online document at: www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php Accessed May22, 2015.
18.
SinhaR, AndersonDE, McDonaldSS, GreenwaldP. Cancer risk and diet in India. J Postgrad Med, 2003; 49:222–228.
19.
AnandP, SundaramC, JhuraniS, et al.Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett, 2008; 267:133–164.
20.
HasimaN, AggarwalBB. Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol, 2012; 3:328–351.
21.
HasimaN, AggarwalBB. Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment. Curr Med Chem, 2014; 21:1583–1594.
22.
RavindranJ, PrasadS, AggarwalBB. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS J, 2009; 11:495–510.
23.
AggarwalBB. Molecular targets and therapeutic use of curcumin [presentation]. 3rd Annual Conference and Expo—Integrative Oncology: IV Therapies 2014, Costa Mesa, CA, January 24–26, 2014.
24.
BhartiAC, DonatoN, AggarwalBB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol, 2003; 171:3863–3871.
25.
ShehzadA, WahidF, LeeYS. Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharmacol (Weinheim), 2010; 343:489–499.
26.
JohnsonJJ, MukhtarH. Curcumin for chemoprevention of colon cancer. Cancer Lett, 2007; 255:170–181.
27.
GoelA, AggarwalBB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer, 2010; 62: 919–930.
28.
National Cancer Institute. Milk Thistle. Accessed May22, 2015.
29.
MannaSK, MukhopadhyayA, VanNT, AggarwalBB. Silymarin suppresses TNF-induced activation of NF-kB, c-JunN-terminal kinase, and apoptosis. J Immunol, 1999; 163:6800–6809.
30.
RamasamyK, AgarwalR. Multitargeted therapy of cancer by silymarin. Cancer Lett, 2008; 269:352–362.
31.
HolmesMD, ChenWY, LiL, et al.Aspirin intake and survival after breast cancer. J Clin Oncol, 2010; 28:1467–1472.
32.
GarlandCF, FrenchCB, BaggerlyLL, HeaneyRP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res, 2011; 31:617–622.
33.
GandiniS, BoniolM, HaukkaJ, et al.Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer, 2011; 128:1414–1424.
34.
MoukayedM, GrantWB. Molecular link between vitamin D and cancer prevention. Nutrients, 2013; 5:3993–4021.
35.
BjelakovicG, GluudLL, NikolovaD, et al.Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev, 2014; 1:CD007470.
36.
GaynorM. The Healing Power of Sound: Recovery from Life-Threatening Illness Using Sound, Voice, and Music. Boston: Shambhala, 2002.
37.
GrassiL, RibaM, eds. Psychopharmacology and Palliative Care. New York: Springer, 2014.
38.
GrassiL, RibaM. Clinical Psycho-Oncology: An International Perspective. New York: Wiley-Blackwell, 2012.
